Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,415 | -18,864 | -16,530 | -66,246 | -53,610 |
| Depreciation Amortization | 4,095 | 2,851 | 1,471 | 4,834 | 3,626 |
| Accounts receivable | 5,082 | 354 | 3,738 | -6,815 | -3,887 |
| Other Working Capital | -5,713 | -11,107 | -294 | -11,124 | -9,822 |
| Other Operating Activity | 4 | 3,132 | -2,022 | 19,141 | 14,058 |
| Operating Cash Flow | $-31,947 | $-23,634 | $-13,637 | $-60,210 | $-49,635 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -281 | -243 | -131 | -663 | -577 |
| Investing Cash Flow | $-281 | $-243 | $-131 | $-663 | $-577 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 70,000 | 70,000 |
| Debt Repayment | N/A | N/A | N/A | -52,944 | -52,944 |
| Common Stock Issued | 62 | 62 | N/A | 39,317 | 112 |
| Other Financing Activity | -96 | -89 | -37 | -6,773 | -6,641 |
| Financing Cash Flow | $-34 | $-27 | $-37 | $49,600 | $10,527 |
| Beginning Cash Position | 49,326 | 49,326 | 49,326 | 60,599 | 60,599 |
| End Cash Position | 17,064 | 25,422 | 35,521 | 49,326 | 20,914 |
| Net Cash Flow | $-32,262 | $-23,904 | $-13,805 | $-11,273 | $-39,685 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,947 | -23,634 | -13,637 | -60,210 | -49,635 |
| Capital Expenditure | -281 | -243 | -131 | -663 | -577 |
| Free Cash Flow | -32,228 | -23,877 | -13,768 | -60,873 | -50,212 |